{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:56:42Z","timestamp":1793548602608,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030898","name":"Institut canadien d'information sur la sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011627","name":"Industrial Research and Consultancy Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012395","name":"Canadian Immunization Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127446","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:01:01Z","timestamp":1752584461000},"page":"127446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Measles seroprevalence among individuals serologically tested in Ontario, Canada"],"prefix":"10.1016","volume":"62","author":[{"given":"Archchun","family":"Ariyarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha S.","family":"Crowcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Bolotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2025.127446_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: a systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"Supplement_1","key":"10.1016\/j.vaccine.2025.127446_bb0010","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1086\/378499","article-title":"Measles elimination in Canada. Katz SL, ed","volume":"189","author":"King","year":"2004","journal-title":"J Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2025.127446_bb0015","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.15585\/mmwr.mm7345a4","article-title":"Progress toward measles elimination \u2014 worldwide, 2000\u20132023","volume":"73","author":"Minta","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127446_bb0020","author":"Statistics Canada"},{"key":"10.1016\/j.vaccine.2025.127446_bb0025","author":"Government of Canada"},{"issue":"46","key":"10.1016\/j.vaccine.2025.127446_bb0030","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.15585\/mmwr.mm7246a3","article-title":"Progress toward measles elimination \u2014 worldwide, 2000\u20132022","volume":"72","author":"Minta","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127446_bb0035","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127446_bb0040","unstructured":"Government of Canada. Measles and rubella weekly monitoring report: Week 23 (June 1 to 7, 2025). Accessed June 21, 2025. https:\/\/health-infobase.canada.ca\/measles-rubella\/."},{"key":"10.1016\/j.vaccine.2025.127446_bb0045","author":"Government of Canada"},{"key":"10.1016\/j.vaccine.2025.127446_bb0050","first-page":"69","article-title":"Measles vaccine coverage and disease outbreaks: a systematic review of the early impact of COVID-19 in low and lower-middle income countries","author":"Packham","year":"2024","journal-title":"Int J Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127446_bb0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/vaccines12060694","article-title":"A world without measles and rubella: Addressing the challenge of vaccine hesitancy","volume":"12","author":"Higgins","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127446_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268800029186","article-title":"The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes","volume":"101","author":"Nokes","year":"1988","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2025.127446_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2015.10.004","article-title":"Understanding herd immunity","volume":"36","author":"Metcalf","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2025.127446_bb0070","series-title":"Observations made during the epidemic of measles on the Faroe Islands in the year 1846","author":"Panum","year":"1940"},{"key":"10.1016\/j.vaccine.2025.127446_bb0075","first-page":"205","article-title":"Measles vaccines: WHO position paper \u2013 April 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2025.127446_bb0080","series-title":"Plotkin\u2019s Vaccines. 7th ed","first-page":"579","article-title":"Measles vaccines","author":"Strebel","year":"2018"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127446_bb0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.97.5.613","article-title":"An evaluation of measles revaccination among school-entry-aged children","volume":"97","author":"Watson","year":"1996","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127446_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.10.090","article-title":"The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness \u2013 a systematic review","volume":"38","author":"Hughes","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127446_bb0095","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/jiac039","article-title":"In elimination settings, measles antibodies wane after vaccination but not after infection: a systematic review and meta-analysis","volume":"226","author":"Bolotin","year":"2022","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127446_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2019.1619402","article-title":"Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study","volume":"15","author":"Bolotin","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127446_bb0105","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.vaccine.2022.04.011","article-title":"Population immunity to measles in Canada using Canadian health measures survey data - a Canadian Immunization Research Network (CIRN) study","volume":"40","author":"Osman","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127446_bb0110","author":"Statistics Canada"},{"key":"10.1016\/j.vaccine.2025.127446_bb0115","series-title":"Immunization Coverage Report for School Pupils in Ontario: 2019\u201320 to 2022\u201323 School Years","author":"Public Health Ontario","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127446_bb0120","author":"Public Health Ontario"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127446_bb0125","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2015.1043499","article-title":"Validation of infant immunization billing codes in administrative data","volume":"11","author":"Schwartz","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127446_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/ciz769","article-title":"Incidence of hospitalizations and emergency department visits for herpes zoster in immunocompromised and immunocompetent adults in Ontario, Canada, 2002\u20132016","volume":"71","author":"Buchan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127446_bb0135","unstructured":"Euroimmun Medizinische Labordiagnostika AG. Anti-Measles Virus ELISA (IgG) Test Instruction."},{"issue":"3","key":"10.1016\/j.vaccine.2025.127446_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127446_bb0145","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127446_bb0150","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/infdis\/jiz380","article-title":"What is the evidence to support a correlate of protection for measles? A systematic review","volume":"221","author":"Bolotin","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127446_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127446_bb0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/EHP.EHP_8_19","article-title":"Survey research methods: a guide for creating post-stratification weights to correct for sample bias","volume":"2","author":"Royal","year":"2019","journal-title":"Educ Health Prof"},{"key":"10.1016\/j.vaccine.2025.127446_bb0165","author":"Khanam"},{"key":"10.1016\/j.vaccine.2025.127446_bb0170","author":"Public Health Ontario"},{"key":"10.1016\/j.vaccine.2025.127446_bb0175","series-title":"Immunization Coverage Report for School Pupils in Ontario: 2013-14, 2014-15 and 2015-16 School Years","author":"Public Health Ontario","year":"2017"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127446_bb0180","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1186\/s12889-023-16258-7","article-title":"Barriers experienced by families new to Alberta, Canada when accessing routine-childhood vaccinations","volume":"23","author":"Fullerton","year":"2023","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127446_bb0185","first-page":"499","article-title":"Measles in Canada--1986 update","volume":"135","author":"Varughese","year":"1986","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2025.127446_bb0190","series-title":"Epidemiology and prevention of vaccine-preventable diseases","article-title":"Measles","author":"Hamborsky","year":"2015"},{"key":"10.1016\/j.vaccine.2025.127446_bb0200","author":"Australian Government"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2025.127446_bb0205","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0264-410X(99)00348-5","article-title":"Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage","volume":"18","author":"Van Den Hof","year":"1999","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2025.127446_bb0210","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2022.07.025","article-title":"Increasing seroprevalence but waning herd immunity against measles after elimination: longitudinal seroepidemiology of measles in Osaka Prefecture, Japan, 2003-2020","volume":"40","author":"Kurata","year":"2022","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2025.127446_bb0215","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/j.vaccine.2017.06.058","article-title":"An increasing, potentially measles-susceptible population over time after vaccination in Korea","volume":"35","author":"Kang","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127446_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.12.002","article-title":"Declining measles antibodies in the era of elimination: Australia\u2019s experience","volume":"36","author":"Gidding","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127446_bb0230","author":"Picot"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127446_bb0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12916-019-1413-7","article-title":"Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination","volume":"17","author":"Funk","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2025.127446_bb0240","series-title":"Plotkin\u2019s Vaccines (Seventh Edition)","first-page":"1512","article-title":"77 - Community protection","author":"Fine","year":"2018"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127446_bb0245","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.vaccine.2022.02.008","article-title":"Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: a retrospective cohort study","volume":"40","author":"Ji","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127446_bb0250","author":"Public Health Ontario"},{"key":"10.1016\/j.vaccine.2025.127446_bb0255","series-title":"Enhanced Epidemiological Summary: Measles in Ontario (Updated June 19, 2025)","author":"Public Health Ontario","year":"2025"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127446_bb0260","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jiph.2023.08.002","article-title":"The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination","volume":"16","author":"Kim","year":"2023","journal-title":"J Infect Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:25:01Z","timestamp":1766546701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S0264410X25007431"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127446","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measles seroprevalence among individuals serologically tested in Ontario, Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127446"}}